At the Cutting Edge of Cardiopulmonary Diagnostics

les Nouvelles - Journal of the Licensing Executives Society, Volume LII No. 4, December 2017

4 Pages Posted: 7 Mar 2018

See all articles by Massimiliano Granieri

Massimiliano Granieri

University of Brescia - Department of Mechanical and Industrial Engineering

Date Written: November 10, 2017

Abstract

Italian company Cosmed has a reputation for laboratory-based medical device products which is founded on sound IP. The market is competitive, with a limited number of players, so reputation is critical to securing a leading role. Patents assure customers that products are innovative. They increase visibility and recognition, and justify premium prices. When co-operating with external partners, IP also makes everyone’s boundaries clear from the start and prevents any confusion moving forward. Medical technology must comply with regulatory requirements in order to enter the market. This takes time, so Cosmed chooses to establish IP early to safeguard its investments.

Keywords: Cosmed, cardiopulmonary diagnostics, IP

Suggested Citation

Granieri, Massimiliano, At the Cutting Edge of Cardiopulmonary Diagnostics (November 10, 2017). les Nouvelles - Journal of the Licensing Executives Society, Volume LII No. 4, December 2017, Available at SSRN: https://ssrn.com/abstract=3068838

Massimiliano Granieri (Contact Author)

University of Brescia - Department of Mechanical and Industrial Engineering ( email )

Via Branze, 38
Brescia, 25123
Italy

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
77
Abstract Views
350
Rank
575,919
PlumX Metrics